在癌症治疗中利用HLA-G的潜力:进展,挑战和前景
Siyuan Wang1,2, Jiaxin Wang3, Yu Xia4,5
1Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China.
Journal of translational medicine
|February 3, 2024
概括
人类白细胞抗原-G (HLA-G) 是癌症治疗的新型免疫检查点标. 研究强调其在免疫抑制中的作用以及作为改善抗癌治疗的生物标志物和治疗点的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 针对PD-1/PD-L1和CTLA-4的免疫检查点抑制剂在癌症治疗中取得了成功,但面临局限性.
- 需要新的免疫治疗点来提高反应率并减少癌症治疗中的不良影响.
研究的目的:
- 提供人类白细胞抗原-G (HLA-G) 表达,免疫功能和与已知的免疫检查点的相互作用的概述.
- 讨论可溶性HLA-G (sHLA-G) 和含有HLA-G的细胞外囊泡 (HLA-G_EV) 作为预测生物标志物的潜力.
- 审查基于HLA-G的疗法在癌症治疗的临床前和临床环境中的进展.
主要方法:
- 文献综述和对HLA-G.当前研究的综合.
- 在各种恶性瘤中分析HLA-G表达模式.
- 评估HLA-G在免疫逃避中的作用及其与免疫细胞的相互作用.
主要成果:
- HLA-G在恶性细胞上富含,阻碍免疫效应细胞并促进免疫抑制.
- 溶解形式的HLA-G (sHLA-G) 和携带HLA-G的细胞外囊泡 (HLA-G_EV) 显示出作为预测生物标志物的潜力.
- HLA-G代表了癌症免疫治疗的有希望的下一代免疫检查点.
结论:
- HLA-G是下一代癌症免疫疗法的关键目标.
- 对基于HLA-G的治疗方法的进一步研究可能会扩大临床应用并改善患者的治疗结果.
- HLA-G及其变体对开发瘤学新型诊断和治疗策略具有前景.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.5K
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
